Gastric Cancer

Title Average Ratingsort ascending
A prospective observational clinical study involving an alternative cancer treatment, psorinum therapy, in treating stomach, gal 100.00%
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. 100.00%
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? 97.50%
Psorinum, the anti cancer miracle from India. 91.47%
The use of mushroom glucans and proteoglycans in cancer treatment. 90.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
Mycoplasma infections and different human carcinomas. 90.00%
To widen the setting of cancer patients who could benefit from metronomic capecitabine. 80.00%
Melatonin as biological response modifier in cancer patients. 80.00%
A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumour Group. 80.00%
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. 70.00%
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. 70.00%
Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells 70.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 60.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. 40.00%